|1|Elevated Expression of Girdin in the Nucleus Indicates Worse Prognosis for Patients with Estrogen Receptor-Positive Breast Cancer. (24793340)
Peng W.T.... Shao Z.M.
|2|Impact of adding the multikinase inhibitor sorafenib to endocrine therapy in metastatic estrogen receptor-positive breast cancer. (24826798)
Massarweh S.... Black E.P.
|3|Breast density and parenchymal texture measures as potential risk factors for Estrogen-Receptor positive breast cancer. (25075270)
Keller B.M.... Kontos D.
|4|Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase. (25212826)
Fu X.... Schiff R.
|5|Optimal management of the premenopausal patient with estrogen receptor-positive breast cancer. (24857090)
Chojecki A.... Toppmeyer D.
|6|Phospho-Aspirin-2 (MDC-22) Inhibits Estrogen Receptor Positive Breast Cancer Growth Both In Vitro and In Vivo by a Redox-Dependent Effect. (25369051)
Huang L.... Rigas B.
|7|The difference in prognostic factors between early recurrence and late recurrence in estrogen receptor-positive breast cancer: nodal stage differently impacts early and late recurrence. (23717438)
Ahn S.G.... Lee H.D.
|8|Targeting BCL-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancer. (23845444)
Vaillant F.... Lindeman G.J.
|9|Methylation of the claudin 1 promoter is associated with loss of expression in estrogen receptor positive breast cancer. (23844228)
Di Cello F.... Zahnow C.A.
|10|Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction. (24213953)
Dahhan T.... Goddijn M.
|11|Soluble interleukin-6 receptor is a prognostic marker for relapse-free survival in estrogen receptor-positive breast cancer. (23902164)
Won H.S.... Kim J.S.
|12|Treatment of estrogen receptor-positive breast cancer. (23278394)
Lumachi F.... Basso S.M.
|13|Use of the neo-adjuvant exemestane in post-menopausal estrogen receptor-positive breast cancer: a randomized phase II trial (PTEX46) to investigate the optimal duration of preoperative endocrine therapy. (23587451)
Hojo T.... Fujiwara Y.
|14|Association of tissue inhibitor of metalloproteinases-1 and Ki67 in estrogen receptor positive breast cancer. (23205744)
Bjerre C.... Laenkholm A.V.
|15|Leptin as a potential target for estrogen receptor-positive breast cancer. (23843844)
Yom C.K.... Noh D.Y.
|16|Beta-naphthoflavone (DB06732) mediates estrogen receptor-positive breast cancer cell cycle arrest through AhR-dependent regulation of PI3K/AKT and MAPK/ERK signaling. (24163404)
Wang C.... Tischkau S.A.
|17|Changes of tumor infiltrating lymphocyte subtypes before and after neoadjuvant endocrine therapy in estrogen receptor-positive breast cancer patients--an immunohistochemical study of Cd8+ and Foxp3+ using double immunostaining with correlation to the pathobiological response of the patients. (23280127)
Chan M.S.... Sasano H.
|18|Functional variable number of tandem repeats variation in the promoter of proto-oncogene PTTG1IP is associated with risk of estrogen receptor-positive breast cancer. (22404099)
Xiang C.... Wang H.
|19|Mouse models of estrogen receptor-positive breast cancer. (22279420)
Mohibi S.... Band V.
|20|Estrogen-mediated upregulation of Noxa is associated with cell cycle progression in estrogen receptor-positive breast cancer cells. (22216287)
Liu W.... Das G.M.
|21|Multi-field-of-view strategy for image-based outcome prediction of multi-parametric estrogen receptor-positive breast cancer histopathology: Comparison to Oncotype DX. (22811953)
Basavanhally A.... Madabhushi A.
|22|Shu-Gan-Liang-Xue Decoction Simultaneously Down-regulates Expressions of Aromatase and Steroid Sulfatase in Estrogen Receptor Positive Breast Cancer Cells. (23467843)
Fu X.S.... Li P.P.
|23|Estrogen receptor-positive breast cancer in Japanese women: trends in incidence, characteristics, and prognosis. (21119029)
Yamashita H.... Kobayashi S.
|24|Bisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancer. (22021667)
Monsees G.M.... Li C.I.
|25|Physician survey of the effect of the 21-gene recurrence score assay results on treatment recommendations for patients with lymph node-positive, estrogen receptor-positive breast cancer. (21731516)
Oratz R.... Broder M.
|26|PRO_10--a new tissue-based prognostic multigene marker in patients with early estrogen receptor-positive breast cancer. (21613801)
Moor A.E.... Aebi S.
|27|Response of estrogen receptor-positive breast cancer tumorspheres to antiestrogen treatments. (21533195)
Ao A.... Lu J.
|28|Understanding the estrogen receptor-positive breast cancer genome: not even the end of the beginning. (21447809)
Van Tine B.A.... Ellis M.J.
|29|Association of FGFR2 gene polymorphism with estrogen receptor positive breast cancer detected by fluorescent quantitative PCR]. (20677155)
Ren L.... Ge J.
|30|Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer. (19844788)
Ellis M.J.... Baselga J.
|31|Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20. (20065188)
Mamounas E.P.... Wolmark N.
|32|The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells. (20086172)
Ariazi E.A.... Jordan V.C.
|33|Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic? (20346095)
Lakhani S.R.... Chenevix-Trench G.
|34|MRP as a new predictive marker of tamoxifen efficiency in treatment of estrogen receptor-positive breast cancer. (20380160)
Bogush T.A.... Davydov M.I.
|35|Adjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer. (20195744)
Paridaens R.J.... Goldhirsch A.
|36|Low expression of a few genes indicates good prognosis in estrogen receptor positive breast cancer. (19619298)
|37|DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy. (19118060)
Hartmann O.... Martens J.W.
|38|Role of AIB1 for tamoxifen resistance in estrogen receptor-positive breast cancer cells. (18827493)
Su Q.... Li F.
|39|Poor outcome in estrogen receptor-positive breast cancers predicted by loss of plexin B1. (17317819)
Rody A.... Kaufmann M.
|40|Tamoxifen induces heparanase expression in estrogen receptor-positive breast cancer. (17634531)
Cohen I.... Elkin M.
|41|Progesterone receptor in estrogen receptor-positive breast cancer: the association between HER-2 and lymph node involvement is age related. (16735717)
Neven P.... Vergote I.
|42|High expression of two genes selected by iAFLP: a new prognostic factor of estrogen receptor-positive breast cancer. (15254706)
Aritake N.... Monden M.
|43|High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancer. (12796397)
Miyoshi Y.... Noguchi S.
|44|Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells. (12444551)
Bindels E.M.... Michalides R.
|45|A therapeutic target for hormone-independent estrogen receptor-positive breast cancers. (11474128)
Biswas D.K.... Pardee A.B.
|46|Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine. (9632722)
Ammanamanchi S.... Brattain M.G.
|47|Adjuvant CMFVP versus adjuvant CMFVP plus ovariectomy for premenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study. (8558219)
Rivkin S.E.... Osborne C.K.
|48|Regarding the dilemma of adjuvant therapy in postmenopausal patients with node-positive, estrogen receptor-positive breast cancer: are we better informed? (7707102)
Roy J.A.... Piccart M.
|49|Influence of different combinations of tamoxifen and toremifene on estrogen receptor-positive breast cancer cell lines. (7553677)
Coradini D.... Di Fronzo G.
|50|Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer. (7079745)
Tamarkin L.... Lippman M.